Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies
JACC: Basic to Translational Science
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies. // JACC: Basic to Translational Science. – URL: https://www.sciencedirect.com/science/article/pii/S2452302X2600241X?dgcid=rss_sd_all
Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies. JACC: Basic to Translational Science. https://www.sciencedirect.com/science/article/pii/S2452302X2600241X?dgcid=rss_sd_all
“Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies.” JACC: Basic to Translational Science.
@article{article118862,
title = {Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies},
journal = {JACC: Basic to Translational Science},
url = {https://www.sciencedirect.com/science/article/pii/S2452302X2600241X?dgcid=rss_sd_all}
}